Cited by — Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer.
No admitted local citation edges point to this work yet.
